BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

20 related articles for article (PubMed ID: 8107307)

  • 1. Quantitative Comparison of the Clinical Efficacy of 6 Classes Drugs for IgA Nephropathy: A Model-Based Meta-Analysis of Drugs for Clinical Treatments.
    Yu J; Luo J; Zhu H; Sui Z; Liu H; Li L; Zheng Q
    Front Immunol; 2022; 13():825677. PubMed ID: 35419000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic immunoglobulin A nephropathy in children and adolescents.
    Hogg RJ
    Pediatr Nephrol; 2010 May; 25(5):823-9. PubMed ID: 19194728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Steroid and cyclophosphamide therapy for IgA nephropathy associated with crescenteric change: an effective treatment.
    McIntyre CW; Fluck RJ; Lambie SH
    Clin Nephrol; 2001 Sep; 56(3):193-8. PubMed ID: 11597033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of treatment with prednisolone or cyclophosphamide-warfarin-dipyridamole combination on the outcome of patients with membranous nephropathy.
    Shearman JD; Yin ZG; Aarons I; Smith PS; Woodroffe AJ; Clarkson AR
    Clin Nephrol; 1988 Dec; 30(6):320-9. PubMed ID: 3243041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The treatment of mesangial IgA nephropathy with cyclophosphamide, dipyridamole and warfarin: a two-year prospective trial.
    Walker RG; Yu SH; Owen JE; Kincaid-Smith P
    Clin Nephrol; 1990 Sep; 34(3):103-7. PubMed ID: 2225560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intensive therapy for clinical remission of active IgA nephropathy: a three-year follow-up study.
    Hotta O; Taguma Y; Kurosawa K; Sudo K; Suzuki K; Horigome I
    Nihon Jinzo Gakkai Shi; 1993 Aug; 35(8):967-73. PubMed ID: 8255008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of steroid therapy for patients with advanced IgA nephropathy and impaired renal function.
    Moriyama T; Honda K; Nitta K; Yumura W; Nihei H
    Clin Exp Nephrol; 2004 Sep; 8(3):237-42. PubMed ID: 15480901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA nephritis: a review of the pathogenetic mechanisms and the rationale for therapy.
    Woo KT
    Ann Acad Med Singap; 1989 Nov; 18(6):702-6. PubMed ID: 2560358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy in children and adolescents with IgA nephropathy.
    Murakami K; Yoshioka K; Akano N; Takemura T; Okada M; Aya N; Hino S; Miyazato H; Yagi K; Maki S
    Nihon Jinzo Gakkai Shi; 1994 Jan; 36(1):38-43. PubMed ID: 8107307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of childhood IgA nephropathy].
    Yoshikawa N
    Nihon Jinzo Gakkai Shi; 2008; 50(4):468-72. PubMed ID: 18546876
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.